Phytochemicals in Malignant Pleural Mesothelioma Treatment—Review on the Current Trends of Therapies
Malignant pleural mesothelioma (MPM) is a rare but highly aggressive tumor of pleura arising in response to asbestos fibers exposure. MPM is frequently diagnosed in the advanced stage of the disease and causes poor prognostic outcomes. From the clinical perspective, MPM is resistant to conventional...
Main Authors: | Malgorzata Chmielewska-Kassassir, Lucyna A. Wozniak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/8279 |
Similar Items
-
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
by: Dario P. Anobile, et al.
Published: (2021-05-01) -
Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting
by: Fabio Nicolini, et al.
Published: (2020-04-01) -
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
by: Fabio Nicolini, et al.
Published: (2020-01-01) -
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
by: Federica Morani, et al.
Published: (2021-03-01) -
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
by: Valentina Coccè, et al.
Published: (2021-06-01)